Monkeypox Virus Update for Tissue Banking Personnel (Group)

Tissue Bank medical directors will provide an overview of the current outbreak of monkeypox caused by the monkeypox virus, focusing on information important to tissue banking. The current worldwide monkeypox outbreak has very low mortality while increasing numbers of individuals impacted increases the possibility of someone dying of other causes with the monkeypox virus. While the likelihood of tissue donors having MPXV is low, understanding the current outbreak will empower tissue banking personnel to feel confident in their ability to recognize monkeypox risk factors, signs, and symptoms.

Andrea Ho, MD, CTBS

Dr. Ho graduated St. Louis University School of Medicine and completed her anatomic and clinical pathology residency program at the University of Missouri, Kansas City. Following her residency, Dr. Ho completed fellowships in Transfusion Medicine and Cytopathology at the University of Colorado. Dr. Ho has been an Associate Medical Director at AlloSource for approximately 2 1/2 years and is a Certified Tissue Bank Specialist. Dr. Ho serves on the AATB Physicians Council and the Monkey Pox Physicians Council Workgroup.

Sally Alrabaa, MD

Medical Director and Associate Professor of Medicine

Dr. Sally Alrabaa currently serves as Associate Professor of Medicine and Infectious Diseases at the University of South Florida College of Medicine and is the Medical Director of LifeLink tissue bank.

In addition, Dr. Alrabaa is the Co-Director of Organ Transplant Infectious Diseases and a member of the Infection Prevention Committee at Tampa General Hospital, a staff physician with the Florida Dept of Health, and a supervising attending physician for tuberculosis services and research.

Inga Gurevich, MD

Associate Medical Director

Dr. Gurevich is currently an Associate Medical Director at AlloSource in Centennial, Colorado. Dr. Gurevich obtained her M.D. degree with honors and Ph.D. from the Saratov State Medical University. Dr. Gurevich completed her Anatomic and Clinical Pathology Residency at Colorado School of Medicine and a two-year Advanced Hematopathology fellowship at the University of Texas M.D. Anderson Cancer Center, Houston. Dr. Gurevich was in practice in the San Diego area and then returned to Denver to complete a two-year Blood Banking and Transfusion Medicine Fellowship at the University of Colorado School of Medicine. Dr. Gurevich has an extensive research background and has publications in leading biomedical journals. Dr. Gurevich serves on the AATB Physicians Council Committee and several Physicians Council Workgroups.